RxDoctor Payments Data

Marsha Ward, NP

Nurse Practitioner · Chillicothe, OHNPI 1073690533

Payments from drug & device makers

$1,081in general payments, 2019–2025

Across 58 payments — averaging $18.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$303
  • Abbott$217
  • Bayer$135
  • Novo Nordisk$132
  • AstraZeneca$48
  • Johnson & Johnson$41
  • plus $206 from 8 others

What the payments were for

  • Food & beverage$1,081100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,081 in reported general payments places this provider in the 85th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$35,720
Medicare patients
187
Services billed
822

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide114$124,013
JardianceEmpagliflozin71$94,338
EliquisApixaban70$68,589
TrulicityDulaglutide57$58,102
Tresiba Flextouch U-200Insulin Degludec53$49,308
MounjaroTirzepatide33$46,817
JanuviaSitagliptin Phosphate27$38,864
XareltoRivaroxaban45$34,438
FarxigaDapagliflozin Propanediol38$34,198
Trelegy ElliptaFluticasone/Umeclidin/Vilanter39$25,835
RybelsusSemaglutide11$17,116
Tresiba Flextouch U-100Insulin Degludec35$10,689
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog18$7,646
Lantus SolostarInsulin Glargine,hum.Rec.Anlog60$7,167
Atorvastatin Calcium502$6,688

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$132$141,129125 claims
Lilly USA, LLCTrulicity, Mounjaro$22$104,91990 claims
PfizerEliquis, Premarin$30$75,24181 claims
MerckJanuvia$15$38,86427 claims
Johnson & JohnsonXarelto$41$34,43845 claims
AstraZenecaFarxiga$48$34,19838 claims
GSKTrelegy Ellipta$24$25,83539 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Chillicothe

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →